STOK
Stoke Therapeutics Inc
25.30$
-3.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -15.3% | +50.5% | +14.6% | +1.3% | +362.1% | +601.2% | -91.3% | -23.1% | -86.8% | +344.3% | +49.7% | – | |
| – | +1.2% | -8.4% | -0.3% | +0.1% | -0.3% | -2.9% | -1.7% | -6.5% | +6.7% | -0.8% | +8.7% | – | |
| – | -24.7% | +95.5% | +19.9% | +31.5% | +362.1% | +601.2% | -91.3% | -30.2% | -96.4% | +1,393.4% | +58.0% | – | |
| – | +7.7% | +3.1% | -5.6% | +7.9% | +5.5% | +39.5% | -20.9% | +44.1% | +10.8% | -3.9% | +23.6% | – | |
| – | +3.3% | -3.7% | +27.6% | -2.6% | +1.2% | +14.1% | +4.2% | +5.0% | +31.9% | -5.5% | +26.4% | – | |
| – | +6.2% | +1.0% | +5.0% | +5.5% | +3.9% | +30.5% | -13.1% | +28.3% | +17.2% | -5.2% | +25.6% | – | |
| – | – | – | – | – | – | – | -124.5% | – | – | – | – | – | |
| – | -2.4% | -6.2% | +52.3% | -4.1% | – | – | +200.0% | +0.0% | +0.0% | +666.7% | -26.1% | – | |
| – | – | – | – | – | – | – | -120.6% | – | – | – | – | – | |
| – | – | -90.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -120.8% | – | – | – | – | – | |
| – | – | – | – | – | – | – | -120.1% | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.